Research for a vaccine has been and continues to be a long process that includes basic laboratory research, product development, and animal experiments. The next step is to test these products on healthy human volunteers through a number of phases. Since 1987, more than thirty HIV candidate vaccines have been tested in approximately sixty phase one and two trials involving more than ten thousand healthy volunteers. Presently, there are only two candidate vaccines being evaluated in phase three trials.